Steven Cohen’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$71M Buy
+1,852,776
New +$48.6M 0.08% 301
2024
Q4
Sell
-1,230,189
Closed -$27.8M 2464
2024
Q3
$27.8M Buy
+1,230,189
New +$25.4M 0.07% 323
2024
Q1
Sell
-497,282
Closed -$27.8M 2635
2023
Q4
$27.8M Sell
497,282
-850,137
-63% -$37M 0.07% 342
2023
Q3
$55.6M Sell
1,347,419
-255,749
-16% -$13.3M 0.16% 149
2023
Q2
$89.5M Buy
1,603,168
+1,066,837
+199% +$57.7M 0.27% 88
2023
Q1
$29.9M Buy
+536,331
New +$25M 0.09% 261
2022
Q1
Sell
-171,462
Closed -$25.5M 1399
2021
Q4
$25.5M Buy
+171,462
New +$26.3M 0.1% 289
2021
Q2
Sell
-23,860
Closed -$4.32M 1176
2021
Q1
$4.32M Sell
23,860
-185,878
-89% -$32.1M 0.02% 600
2020
Q4
$29.7M Buy
209,738
+112,661
+116% +$16.3M 0.14% 198
2020
Q3
$12.1M Buy
97,077
+55,992
+136% +$5.88M 0.06% 371
2020
Q2
$3.67M Sell
41,085
-213,960
-84% -$16.7M 0.02% 523
2020
Q1
$15.9M Buy
+255,045
New +$19.9M 0.13% 233
2019
Q4
Sell
-400
Closed -$20K 1261
2019
Q3
$20K Buy
+400
New +$22.1K ﹤0.01% 1073

Other funds holding TXG

Steven Cohen's TXG Position: Q2 2026 in Review

Steven Cohen opened a new position in 10x Genomics (TXG) in Q2 2026: 1,852,776 shares worth $71M. The stake represents 0.08% of the portfolio and ranks #301 among its holdings. This is a return to the name: Steven Cohen previously reported a position in TXG as recently as Q3 2024.

Steven Cohen first reported a position in TXG in Q3 2019 and has held it in 13 quarters since. The position peaked at $89.5M in Q2 2023. 389 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Steven Cohen held 1,852,776 shares of 10x Genomics worth $71M as of Q2 2026.
  • 10x Genomics was a new Steven Cohen position in Q2 2026.
  • 10x Genomics made up 0.08% of Steven Cohen's portfolio in Q2 2026, its #301 holding.
  • Steven Cohen first reported a position in 10x Genomics in Q3 2019 and has held it in 13 quarters since.
  • Steven Cohen's 10x Genomics position peaked at $89.5M in Q2 2023.
  • 389 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.